 RESEARCH TRIANGLE PARK, N.C.--BUSINESS WIRE--TransEnterix, Inc. NYSE American: TRXC TransEnterix or the Company, a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis 23,083,333 shares of common stock of the Company at a public offering price of 3 